These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 9921004

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The effect of Tauredon on the development of non-specific indicators of inflammatory activity in patients with rheumatoid arthritis].
    Vlak T, Jajić Z.
    Reumatizam; 1992; 39(1):19-22. PubMed ID: 1366140
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate.
    Iqbal MS, Saeed M, Taqi SG.
    Biol Trace Elem Res; 2008; 126(1-3):56-64. PubMed ID: 18649049
    [Abstract] [Full Text] [Related]

  • 6. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M, Kaik B, Muller-Fassbender H, Rau R, Zeidler H.
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin.
    Menard HA, Beaudet F, Davis P, Harth M, Percy JS, Russell AS, Thompson JM.
    J Rheumatol Suppl; 1982; 8():179-83. PubMed ID: 6813482
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of actarit combination therapy in patients with active rheumatoid arthritis resistant to gold agents].
    Sakurai T, Iso T, Inoue H, Sano K, Takeuchi K, Takagishi K.
    Ryumachi; 2001 Jun; 41(3):635-45. PubMed ID: 11505513
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D, Brook A, Brooks P, Boyden K, Thomas D, Tymms K.
    J Rheumatol Suppl; 1982 Jun; 8():197-200. PubMed ID: 6813485
    [Abstract] [Full Text] [Related]

  • 15. [The effect of Na-aurothiomalate on circulating immune complex dynamics in patients with rheumatoid arthritis].
    Vlak T, Jajić I.
    Reumatizam; 1992 Jun; 39(2):1-5. PubMed ID: 1366145
    [Abstract] [Full Text] [Related]

  • 16. Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials.
    Dahl SL, Samuelson CO, Williams HJ, Ward JR, Karg M.
    Pharmacotherapy; 1990 Jun; 10(2):79-84. PubMed ID: 2112243
    [Abstract] [Full Text] [Related]

  • 17. Auranofin: first choice for remission-inducing drug (RID) therapy in rheumatoid arthritis?
    Bandilla K, Missler B, Klein-Reesink B.
    Scand J Rheumatol Suppl; 1986 Jun; 63():47-54. PubMed ID: 3474777
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sulfasalazine has a better efficacy/toxicity profile than auranofin--evidence from a 5 year prospective, randomized trial.
    McEntegart A, Porter D, Capell HA, Thomson EA.
    J Rheumatol; 1996 Nov; 23(11):1887-90. PubMed ID: 8923361
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.